Log in

Electromed Stock Forecast, Price & News

+0.29 (+2.79 %)
(As of 09/18/2020 12:00 AM ET)
Today's Range
Now: $10.70
50-Day Range N/A
52-Week Range
Now: $10.70
Volume149,636 shs
Average Volume148,212 shs
Market Capitalization$91.90 million
P/E RatioN/A
Dividend YieldN/A
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products in the United States and internationally. The company offers SmartVest airway clearance system that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to patients with compromised pulmonary function; and SmartVest SQL System that provides advanced generator programmability and an enhanced pause feature with save, lock, and restore functionality. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers working in intensive care units; and Aerobika, an oscillating positive expiratory pressure device. The company offers its products primarily to home health care market for patients with chronic lung issues, including bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was founded in 1992 and is headquartered in New Prague, Minnesota.
Read More
Electromed logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.96 out of 5 stars

Industry, Sector and Symbol

Industry Medical Devices
Previous SymbolNYSEMKT:ELMD



Sales & Book Value

Annual SalesN/A



Market Cap$91.90 million
Next Earnings Date11/10/2020 (Estimated)
OptionableNot Optionable
+0.29 (+2.79 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ELMD News and Ratings via Email

Sign-up to receive the latest news and ratings for ELMD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Electromed (NYSEAMERICAN:ELMD) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Electromed?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Electromed in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Electromed

When is Electromed's next earnings date?

Electromed is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020.
View our earnings forecast for Electromed

How were Electromed's earnings last quarter?

Electromed, Inc. (NYSEAMERICAN:ELMD) posted its earnings results on Tuesday, May, 12th. The medical equipment provider reported $0.07 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.06 by $0.01. The medical equipment provider had revenue of $8.74 million for the quarter.
View Electromed's earnings history

What price target have analysts set for ELMD?

1 brokerages have issued 1 year target prices for Electromed's shares. Their forecasts range from $12.00 to $12.00. On average, they expect Electromed's stock price to reach $12.00 in the next twelve months. This suggests a possible upside of 12.1% from the stock's current price.
View analysts' price targets for Electromed

Are investors shorting Electromed?

Electromed saw a drop in short interest in August. As of August 14th, there was short interest totaling 301,000 shares, a drop of 16.0% from the July 30th total of 358,400 shares. Based on an average daily volume of 142,000 shares, the days-to-cover ratio is presently 2.1 days. Currently, 4.7% of the company's shares are short sold.
View Electromed's Short Interest

Who are some of Electromed's key competitors?

What other stocks do shareholders of Electromed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Electromed investors own include AbbVie (ABBV), TransEnterix (TRXC), AT&T (T), Crispr Therapeutics (CRSP), Inseego (INSG), Novavax (NVAX), NVIDIA (NVDA), Pfizer (PFE), Protalix Biotherapeutics (PLX) and Rigel Pharmaceuticals (RIGL).

Who are Electromed's key executives?

Electromed's management team includes the following people:
  • Ms. Kathleen S. Skarvan, CEO, Pres & Director (Age 63)
  • Mr. Jeremy T. Brock CPA, CFO, Principal Accounting Officer & Financial Controller (Age 40)
  • Mr. Bud Reeves, VP of Sales
  • Mr. William J. George J.D., Sec. (Age 70)
  • Ms. Kathryn Thompson, VP of Reimbursement

What is Electromed's stock symbol?

Electromed trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ELMD."

Who are Electromed's major shareholders?

Electromed's stock is owned by a variety of institutional and retail investors. Top institutional investors include EAM Investors LLC (2.46%), Bridgeway Capital Management Inc. (1.67%), Cadence Capital Management LLC (1.09%), Essex Investment Management Co. LLC (1.04%), Teton Advisors Inc. (0.72%) and Globeflex Capital L P (0.65%). Company insiders that own Electromed stock include George H Winn and Stephen H Craney.
View institutional ownership trends for Electromed

Which institutional investors are selling Electromed stock?

ELMD stock was sold by a variety of institutional investors in the last quarter, including Teton Advisors Inc., Essex Investment Management Co. LLC, Bridgeway Capital Management Inc., and Advisor Group Holdings Inc..
View insider buying and selling activity for Electromed

Which institutional investors are buying Electromed stock?

ELMD stock was bought by a variety of institutional investors in the last quarter, including EAM Investors LLC, Globeflex Capital L P, Bank of New York Mellon Corp, 1492 Capital Management LLC, Creative Planning, Two Sigma Advisers LP, Nuveen Asset Management LLC, and Charles Schwab Investment Management Inc..
View insider buying and selling activity for Electromed

How do I buy shares of Electromed?

Shares of ELMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Electromed's stock price today?

One share of ELMD stock can currently be purchased for approximately $10.70.

How big of a company is Electromed?

Electromed has a market capitalization of $91.90 million. Electromed employs 132 workers across the globe.

What is Electromed's official website?

The official website for Electromed is smartvest.com.

How can I contact Electromed?

Electromed's mailing address is 500 6th Ave NW, NEW PRAGUE, MN 56071-1134, United States. The medical equipment provider can be reached via phone at +1-952-7589299.

This page was last updated on 9/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.